Literature DB >> 20442648

Physiology and pathophysiology with ascent to altitude.

Biff F Palmer1.   

Abstract

With increasing altitude, there is a fall in barometric pressure and a progressive fall in the partial pressure of oxygen. Acclimatization describes the physiologic changes that help maintain tissue oxygen delivery and human performance in the setting of hypobaric hypoxemia. These changes include a marked increase in alveolar ventilation, increased hemoglobin concentration and affinity, and increased tissue oxygen extraction. In some individuals, these physiologic changes may be inadequate, such that the sojourn to altitude and the attendant hypoxia are complicated by altitude-associated medical illness. The rate of ascent, the absolute change in altitude, and individual physiology are the primary determinants whether illness will develop or not. The most common clinical manifestations of altitude illness are acute mountain sickness, high altitude pulmonary edema, and high altitude cerebral edema.

Entities:  

Mesh:

Year:  2010        PMID: 20442648     DOI: 10.1097/MAJ.0b013e3181d3cdbe

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  15 in total

Review 1.  From system to organ to cell: oxygenation and perfusion measurement in anesthesia and critical care.

Authors:  Patrick Schober; Lothar A Schwarte
Journal:  J Clin Monit Comput       Date:  2012-03-22       Impact factor: 2.502

Review 2.  Interventions for preventing high altitude illness: Part 1. Commonly-used classes of drugs.

Authors:  Víctor H Nieto Estrada; Daniel Molano Franco; Roger David Medina; Alejandro G Gonzalez Garay; Arturo J Martí-Carvajal; Ingrid Arevalo-Rodriguez
Journal:  Cochrane Database Syst Rev       Date:  2017-06-27

3.  Interventions for preventing high altitude illness: Part 3. Miscellaneous and non-pharmacological interventions.

Authors:  Daniel Molano Franco; Víctor H Nieto Estrada; Alejandro G Gonzalez Garay; Arturo J Martí-Carvajal; Ingrid Arevalo-Rodriguez
Journal:  Cochrane Database Syst Rev       Date:  2019-04-23

4.  Targeted Sequencing Identifies the Genetic Variants Associated with High-altitude Polycythemia in the Tibetan Population.

Authors:  Zhiying Zhang; Lifeng Ma; Xiaowei Fan; Kun Wang; Lijun Liu; Yiduo Zhao; ZhiPeng Zhao; Han Zhang; Tian Liang; Wenxue Dong; Peng Cai; Yansong Li; Jing Li; Songhua Zhou; Longli Kang
Journal:  Indian J Hematol Blood Transfus       Date:  2021-08-03       Impact factor: 0.915

Review 5.  Interventions for treating acute high altitude illness.

Authors:  Daniel Simancas-Racines; Ingrid Arevalo-Rodriguez; Dimelza Osorio; Juan Va Franco; Yihan Xu; Ricardo Hidalgo
Journal:  Cochrane Database Syst Rev       Date:  2018-06-30

Review 6.  Interventions for preventing high altitude illness: Part 2. Less commonly-used drugs.

Authors:  Alejandro Gonzalez Garay; Daniel Molano Franco; Víctor H Nieto Estrada; Arturo J Martí-Carvajal; Ingrid Arevalo-Rodriguez
Journal:  Cochrane Database Syst Rev       Date:  2018-03-12

Review 7.  Non-high altitude methods for rapid screening of susceptibility to acute mountain sickness.

Authors:  Han Song; Tao Ke; Wen-Jing Luo; Jing-Yuan Chen
Journal:  BMC Public Health       Date:  2013-09-30       Impact factor: 3.295

8.  Hypoxia and hypoxia mimetics decrease aquaporin 5 (AQP5) expression through both hypoxia inducible factor-1α and proteasome-mediated pathways.

Authors:  Jitesh D Kawedia; Fan Yang; Maureen A Sartor; David Gozal; Maria Czyzyk-Krzeska; Anil G Menon
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

Review 9.  Effects of high altitude on sleep and respiratory system and theirs adaptations.

Authors:  Turhan San; Senol Polat; Cemal Cingi; Gorkem Eskiizmir; Fatih Oghan; Burak Cakir
Journal:  ScientificWorldJournal       Date:  2013-04-17

10.  Mitochondrial DNA 10609T promotes hypoxia-induced increase of intracellular ROS and is a risk factor of high altitude polycythemia.

Authors:  Chunhua Jiang; Jianhua Cui; Fuyu Liu; Liang Gao; Yongjun Luo; Peng Li; Libin Guan; Yuqi Gao
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.